Description
Product details
Introduction Living with chronic joint pain, stiffness, and inflammation can quietly affect every part of daily life—from simple movements like walking and gripping objects to maintaining an active professional and social routine. Autoimmune conditions such as rheumatoid arthritis often progress slowly but steadily, making early and effective treatment essential for long-term joint health and quality of life. IBRUNITIME 25, containing Iguratimod 25 mg, is a disease-modifying antirheumatic drug (DMARD) developed to address the root cause of inflammatory joint diseases rather than merely masking symptoms. Unlike conventional painkillers that offer temporary relief, IBRUNITIME 25 works at the immune system level to reduce inflammation, slow joint damage, and improve overall physical function. This medication is widely prescribed as part of long-term management strategies for inflammatory arthritis, particularly rheumatoid arthritis, helping patients regain mobility, reduce pain, and protect joint structure over time. Composition Active Ingredient: Iguratimod 25 mg Brand Name: IBRUNITIME 25 Dosage Form: Oral Tablet Iguratimod is known for its immunomodulatory and anti-inflammatory properties, making it a valuable option in modern rheumatology care. How IBRUNITIME 25 Works Iguratimod works differently from standard anti-inflammatory medicines. Instead of only reducing pain signals, it directly influences immune system activity that leads to chronic inflammation. Key mechanisms include: Suppression of inflammatory cytokines such as interleukin-6 (IL-6) Reduction of autoantibody production Inhibition of processes that cause joint cartilage and bone damage By targeting these underlying mechanisms, IBRUNITIME 25 helps slow disease progression and preserves joint integrity over time. Uses of IBRUNITIME 25 1. Rheumatoid Arthritis (RA) The primary use of IBRUNITIME 25 is in the treatment of rheumatoid arthritis, a chronic autoimmune disorder characterized by joint pain, swelling, stiffness, and progressive joint destruction. 2. Inflammatory Joint Disorders IBRUNITIME 25 may also be prescribed in other inflammatory joint conditions where immune-mediated inflammation plays a significant role. 3. Combination Therapy It is often used alongside other DMARDs such as methotrexate, depending on disease severity and patient response, to enhance treatment outcomes. Key Benefits of IBRUNITIME 25 1. Reduces Joint Pain and Swelling Regular use helps significantly decrease pain, tenderness, and swelling in affected joints, making daily activities more manageable. 2. Improves Joint Mobility By controlling inflammation, IBRUNITIME 25 improves flexibility and range of motion, allowing patients to move more comfortably. 3. Slows Disease Progression Unlike pain relievers, this medication helps slow the progression of rheumatoid arthritis and reduces long-term joint damage. 4. Targets the Root Cause IBRUNITIME 25 works on immune pathways responsible for chronic inflammation, offering more comprehensive disease control. 5. Enhances Quality of Life With better pain control, improved mobility, and reduced stiffness, patients often experience improved physical independence and emotional well-being. 6. Suitable for Long-Term Use When taken under medical supervision, it is designed for long-term disease management rather than short-term symptom relief. Dosage and Administration The usual recommended dose is Iguratimod 25 mg, taken once or twice daily, as prescribed by a healthcare professional. Tablets should be swallowed whole with water. It can be taken with or after food to minimize stomach discomfort. Dosage duration depends on disease severity, response to treatment, and physician guidance. Important: Do not adjust the dose or stop the medication without consulting your doctor, even if symptoms improve. Possible Side Effects of IBRUNITIME 25 Like all medications, IBRUNITIME 25 may cause side effects, although not everyone experiences them. Most side effects are mild to moderate and manageable with proper medical supervision. Common Side Effects Mild stomach discomfort Nausea Diarrhea Dizziness Headache Less Common Side Effects Elevated liver enzymes Fatigue Skin rash Loss of appetite Rare but Serious Side Effects Liver function abnormalities Severe allergic reactions Significant gastrointestinal issues Patients are usually advised to undergo periodic blood tests to monitor liver function and overall health during treatment. Precautions and Warnings Liver Health: Patients with existing liver disorders should use IBRUNITIME 25 cautiously and only under medical supervision. Pregnancy and Breastfeeding: Not recommended unless clearly advised by a doctor. Alcohol Consumption: Excessive alcohol intake should be avoided due to potential liver strain. Infections: Inform your doctor if you have active or recurrent infections, as immune modulation may affect infection resistance. Drug Interactions: Always disclose current medications, supplements, or herbal products to your healthcare provider. Who Should Avoid IBRUNITIME 25? Individuals with severe liver disease Patients with known hypersensitivity to Iguratimod Pregnant or breastfeeding women (unless specifically prescribed) Storage Instructions Store at room temperature Keep away from moisture and direct sunlight Keep out of reach of children Do not use after the expiry date Conclusion IBRUNITIME 25 (Iguratimod 25 mg) represents a modern, targeted approach to managing rheumatoid arthritis and chronic inflammatory joint disorders. By addressing the immune-driven causes of inflammation rather than simply relieving pain, it offers long-term benefits such as reduced joint damage, improved mobility, and enhanced quality of life. When used responsibly under medical supervision, IBRUNITIME 25 can become an essential part of a comprehensive arthritis management plan—helping patients move with confidence, reduce daily discomfort, and regain control over their health journey. If you or your patients are seeking a dependable disease-modifying therapy that balances effectiveness with tolerability, IBRUNITIME 25 stands as a reliable and clinically valuable option in rheumatology care.
